Concentrations of stiripentol in children and adults with epilepsy: the influence of dose, age, and comedication.
2012
Background:Stiripentol (STP) was approved as an orphan drug in 2007 in Europe as adjunctive therapy with valproic acid (VPA) and clobazam (CLB) for Dravet syndrome. Dravet syndrome is a highly pharmacoresistant form of epilepsy, which starts in early childhood. Data about STP pharmacokinetics and in
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
26
References
33
Citations
NaN
KQI